Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab-Reference-Cited by-同舟云学术

Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab

Published:2023-06 Issue:6 Volume:16 Page:100788
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Doan Serge,Papadopoulos Nikolaos G.,Lee Jason K.,Leonardi Salvatore,Manti Sara,Lau Susanne,Rondon Carmen,Sharma Vibha,Pleyer Uwe,Jaumont Xavier,Lazarewicz Slawomir B.

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference67 articles.

1. Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: our experience and literature review;Manti;Immun Inflamm Dis,2021

2. Omalizumab in three children with severe vernal keratoconjunctivitis;Rossberg;Allergo J Int,2020

3. Omalizumab. An option in vernal keratoconjunctivitis?;Sanchez;Allergol Immunopathol (Madr),2012

4. Prevalence of vernal keratoconjunctivitis: a rare disease?;Bremond-Gignac;Br J Ophthalmol,2008

5. Epidemiology of vernal keratoconjunctivitis in the United States: a claims data analysis;Babineaux;Investig Ophthalmol Vis Sci,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators;Life;2024-03-09

2. Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis;Indian Journal of Ophthalmology;2024-03-08

3. Vernal Keratoconjunctivitis: A Systematic Review;Clinical Reviews in Allergy & Immunology;2023-09-02